Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
ASCP Corner
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Rosanne Lane, MAS
JCP
Original Research
Esketamine Nasal Spray Rapidly Reduces Depression
May 12, 2020
There is an unmet need in patients with depression and active suicidal ideation for new therapies that can rapidly bridge the gap until antidepressants take effect. Read this article...
Dong-Jing Fu
,
Dawn F. Ionescu
,
Xiang Li
, et al
JCP
Original Research
Esketamine Nasal Spray Plus for Depression
April 28, 2020
Read a study about esketamine nasal spray (oral antidepressant) and it's long-term safety, tolerability, and efficacy for treatment-resistant depression (TRD).
Ewa Wajs
,
Leah Aluisio
,
Richard Holder
, et al
JCP
Original Research
Efficacy and Tolerability of Oral Paliperidone Extended-Release Tablets in the Treatment of Acute Schizophrenia: Pooled Data From Three 6-Week, Placebo-Controlled Studies
May 11, 2008
Herbert Y. Meltzer
,
William V. Bobo
,
Isaac F. Nuamah
, et al
